|
|
Article: Geron to Present at Four Investor Conferences.(Conference news)
- Article from:
- Business Wire
- Article date:
- August 31, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
MENLO PARK, Calif. -- Geron Corporation (Nasdaq:GERN) today announced that the company will present updates of its product development programs at four investor conferences in the month of September.
Stephen M. Kelsey, M.D., F.R.C.P., F.R.C.Path., executive vice president and chief medical officer for oncology, will review Geron's portfolio of anti-cancer therapies, including its telomerase inhibitor drug (imetelstat - GRN163L) and its telomerase therapeutic vaccine (GRNVAC1) at the following conference:
* Rodman & Renshaw 11th Annual Healthcare Conference in New York, NY, at 9:35 am ET on Thursday, September 10, 2009.
Thomas B. Okarma, Ph.D., ...